The JAK2 Blocker TG101209 Is a Potent Inhibitor of Clonogenic Progenitor Cell Growth in Patients With Chronic Myeloid Leukaemia

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14508
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Stochastic Modelling of Tyrosine Kinase Inhibitor Rotation Therapy in Chronic Myeloid Leukaemia

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia

Oncology and Therapy
Oncology
2019English

Cognitive Dysfunction After Withdrawal of Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia

American Journal of Hematology
Hematology
2016English

Neonatal Chronic Myeloid Leukaemia With Prolonged Survival

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1983English

Sweet Syndrome in Chronic Myeloid Leukaemia.

Postgraduate Medical Journal
Medicine
1995English

Chronic Myeloid Leukaemia and Pregnancy

BMJ
1950English

Gynaecomastia in Men With Chronic Myeloid Leukaemia After Imatinib

The Lancet
Medicine
2003English

Long-Term Impact of Molecular Response Fluctuations in Chronic Myeloid Leukaemia Patients Treated With Imatinib

British Journal of Haematology
Hematology
2017English

Modelling Predictors of Molecular Response to Frontline Imatinib for Patients With Chronic Myeloid Leukaemia

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy